[12] Accordingly, improved administration of exogenous BDNF and consequent neuroprotection as well as neuroregeneration have been considered potentially novel treatments for neurodegenerative diseases, including Parkinson’s disease. This evidence concerns the gene BDNF and Parkinson disease.